Multiple Sclerosis Home Treatment Equity Act of 1994
Official title: To amend Title XVIII of the Social Security Act to provide for coverage of self-administered Betaseron treatments for Multiple Sclerosis under the Medicare program, and for other purposes.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the Subcommittee on Health and the Environment.
Multiple Sclerosis Home Treatment Equity Act of 1994 - Amends title XVIII (Medicare) of the Social Security Act (SSA) to provide coverage and payment for self-administered betaseron (Interferon beta-1b) for patients with multiple sclerosis.
- Introduced in House Formatted Text PDF
Cite this page
U.S. Congress. (2026). H.R. 4610: Multiple Sclerosis Home Treatment Equity Act of 1994. 103rd Congress. Open America. https://openamerica.io/bill/103-HR-4610/
"H.R. 4610: Multiple Sclerosis Home Treatment Equity Act of 1994." 103rd Congress, 2026, Open America, https://openamerica.io/bill/103-HR-4610/.
H.R. 4610, 103rd Cong. (2026), https://openamerica.io/bill/103-HR-4610/.
[H.R. 4610: Multiple Sclerosis Home Treatment Equity Act of 1994](https://openamerica.io/bill/103-HR-4610/)